Skip to content

Development of Novel Adhesive Sports Tape Modular to Facilitate Use of Discomfort

Development of Novel Adhesive Sports Tape Modular to Facilitate Use of Discomfort

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04025619
Enrollment
86
Registered
2019-07-19
Start date
2018-03-12
Completion date
2019-06-20
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Brief summary

Special metals (e.g. Germanium, Titanium, and π element) can be used to produce far-infrared radiation. The applications of these metals in promoting blood circulation are worth investigating. This clinical trial recruited subjects for using tape made up of Ge, Ti, and π element developed by Green Energy Nano Technology Co., Ltd. We assumed that the experimental tape can improve the participants' peripheral blood circulation and their quality of life. In this clinical trial, the clinical efficacy and safety of the test products were assessed using physical examination and questionnaires.

Detailed description

This study is made of two open-labeled, two-arm studies. 20 to 80 years old patient diagnosed with varicose veins were included in the study. Besides, patient with the following characteristics was excluded: vulnerable group, patient with an open wound at lower limb which cannot be taped, unable to express willingness clearly, Dyslexia, and inability to ambulate. The final number of total participant is 86 participants and 66 out of 86 participants were assigned to the first study which is divided into 2 groups, the experimental and control group. The experimental group received the experimental tape as treatment, and the control group didn't receive any treatment. The participants will fill in the questionnaires including visual Analogue Scale and quality of life on the first day of the study, and fill the same questionnaires seven days later. Furthermore, the rest of the 20 participants were assigned to the second study. The researchers evaluate their peripheral blood circulation by Segmental Blood Pressure over Pulse Volume Recording (SBP/PVR), Maximum Venous Outflow over Segmental Venous Capacitance (MVO/SVC), and Ankle Brachial Index (ABI) before they received the treatment, then the researchers inspect the same indexes after they received the treatment right after the first tests.

Interventions

DEVICEtape

Sports tape

Sponsors

National Defense Medical Center, Taiwan
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

2 groups of participant, one of the group took the questionnaire then received the intervention for seven days, then took the same questionnaire again. The other group took the physical examination and received the intervention immediately, then took the physical examination again when the intervention is on the treating area.

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Cardiovascular disease (deep Vein Thrombosis or Chronic venous insufficiency)

Exclusion criteria

* Vulnerable populations * wound at lower limb which can not take the intervention * one can not make express consent clearly * dyslexia * who need physical assistance during ambulation * nonfunctional ambulator

Design outcomes

Primary

MeasureTime frameDescription
Ankle-Brachial Pressure Index1 dayDetect the pressure difference in percentage between brachial pressure and ankle pressure by the pulse volume record and ultrasound device.
MVO/SVC1 dayThe ratio of maximum venous outflow (MVO) to the segmental venous capacitance (SVC)
Visual Analog Scale (VAS) Pain1 dayVAS is measurement instrument for describing pain severity or intensity. The pain scale is range from 0 to 10, representing no hurt to hurt worst, respectively.

Secondary

MeasureTime frameDescription
Kidney Disease Quality of LifeDay 0 (before intervention) and Day 7 (after using the intervention for 7 days)Questionnaire to assess generic and kidney-disease targeted aspects of quality of life

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026